Cleveland Diagnostics, Inc. has named Michael Iskra as its new Chief Executive Officer to drive strategic and accelerated growth following the FDA approval of IsoPSA. Iskra will focus on scaling the commercial adoption of the IsoPSA IVD Assay kit.
Who to call at Cleveland Diagnostics, and when
A new leader at Cleveland Diagnostics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Cleveland Diagnostics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Cleveland Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cleveland Diagnostics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Cleveland Diagnostics
Location
Cleveland, Ohio, United States
About
Cleveland Diagnostics is a precision oncology company focused on changing the shape of cancer detection. The company has unlocked the diagnostic power of protein structure with its revolutionary IsoClear™ platform that enables novel diagnostics based on a cancer-specific, protein structure-based assessment using easy to execute tests within the clinical lab setting.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cleveland Diagnostics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ClevelandBiotechnologyFinancial ServicesHealth CareMedicalHealth Diagnostics